REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Viapharma S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Viapharma S.R.O. Profile Updated: February 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Viapharma S.R.O is a pharmaceutical distribution company. It operates as a distributor of drugs for pharmacies and hospitals, using the latest technology in warehouses. The company targets the domestic market and focuses on distributing pharmaceutical products.

Headquarters
Na Florenci 2116/15
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Viapharma S.R.O. report to view the information.

Website: http://viapharma.cz/

Basic Information
Total Employees:
Purchase the Viapharma S.R.O. report to view the information.
Registered Capital:
Purchase the Viapharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Viapharma S.R.O. report to view the information.
Incorporation Date:
February 21, 1991
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Pharmdata, S.R.O.
33.33%
Company Performance
Financial values in the chart are available after Viapharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
6.15%▲
Total operating revenue
5.61%▲
Operating Profit/Loss (EBIT)
20.51%▲
EBITDA
19.26%▲
Net Profit/Loss for the Period
17.5%▲
Total Assets
13.01%▲
Total Equity
22.36%▲
Operating Profit Margin (ROS)
0.53%▲
Net Profit Margin
0.32%▲
Return on Equity (ROE)
-0.75%▼
Quick Ratio
0.26%▲

Similar companies

Phoenix Lekarensky Velkoobchod, S.R.O.
 
Alliance Healthcare S.R.O.
Zentiva, K.S.
 
Pharmos, A.S.
Solvent Cr S.R.O.
 
Sanofi S.R.O.
Glenmark Pharmaceuticals S.R.O.
 
Astrazeneca Czech Republic S.R.O.
Noviko S.R.O.
 
Glaxosmithkline, S.R.O.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo